Senior Product Manager, Oncology, Hereditary Cancer & Germline Testing

Labcorp • Durham, NC

1d • $150,000 - $160,000 • Hybrid

About The Position

The Senior Product Manager is responsible for driving product strategy and managing tests and services within Labcorp’s oncology portfolio, with a dedicated focus on hereditary and germline cancer testing. The role is accountable for delivering highly differentiated solutions that support risk assessment, early detection, prevention, and treatment decision‑making, while providing an optimal client ordering‑to‑reporting experience. This role addresses key customer needs across oncology, genetics, and women’s health, aligns with evolving clinical guidelines and payer requirements, and drives achievement of growth, access, and margin objectives across the hereditary cancer portfolio. This individual will collaborate deeply with Oncology and Genetics Product Marketing, Customer Marketing, Science, Medical Affairs, Commercial Strategy, Market Access, RCM, Digital, and Operations teams to ensure customer insights, clinical evidence, and market dynamics inform product strategy and go‑to‑market execution. The role requires high levels of cross‑functional collaboration and external engagement with oncologists, genetic counselors, surgeons, OB‑GYNs, primary care providers, pathologists, and hereditary cancer thought leaders.

Requirements

• Bachelor’s degree in Molecular Biology, Life Sciences or Genetics
• 3 or more years in the biotech, medtech, pharma or diagnostic industry.
• 3 or more years managing diagnostic services.
• Demonstrated success developing and commercializing regulated diagnostic products.
• Experience working with regulated clinical diagnostics products.
• Ability to design and communicate product strategies across the full lifecycle.
• Expertise in centralized laboratory services and distributed diagnostic solutions.
• Deep understanding of provider, health system, and consumer‑adjacent testing models.
• Strong knowledge of U.S. diagnostic reimbursement and access dynamics.
• Technical understanding of germline genetics, NGS platforms, and variant interpretation.
• Strong financial and analytical skills.
• Proven cross‑functional collaboration and stakeholder leadership.
• Understanding of consent, privacy, and ethical considerations in genetic testing.
• Experience engaging genetic counselors and hereditary cancer KOLs.

Nice To Haves

• Advanced degree in Genetics, Molecular Biology or Life Sciences.
• Master’s degree in Business Administration (MBA).
• 3 or more years in hereditary or germline genetic testing.

Responsibilities

• Drive lifecycle strategy, product ownership, and management of hereditary cancer and germline testing services from initiation through sunset.
• Develop and execute multi‑year product strategies grounded in customer insights, clinical guideline evolution, and reimbursement dynamics.
• Build comprehensive business cases including segmentation, financial modeling, value propositions, and risk management.
• Analyze customer feedback, utilization, access metrics, and portfolio KPIs to drive performance improvement.
• Represent the voice of the customer in product governance and lifecycle forums.
• Facilitate alignment across stakeholders on product evolution, pricing, and portfolio strategy.
• Forecast performance, track adoption, and advise senior leadership on growth opportunities.
• Partner with Product Marketing, Medical Affairs, Science, and Market Access on launch and commercialization strategies.
• Build and maintain relationships with customers, KOLs, professional societies, and advocacy organizations.
• Own the hereditary cancer portfolio roadmap including multi‑gene germline panels, targeted testing, and tumor‑normal workflows.
• Translate NCCN, ACMG, ASCO, and specialty guidelines into product strategy and testing pathways.
• Design optimized end‑to‑end customer experiences including eligibility logic, consent models, and structured clinical reporting.
• Lead access and reimbursement strategies emphasizing prevention, early detection, and downstream cost avoidance.
• Drive evidence generation including clinical utility, HEOR, and real‑world evidence.
• Segment commercialization strategies across oncology, genetics, OB‑GYN, primary care, and health system programs.
• Develop cascade testing strategies to improve identification and testing of at-risk family members.
• Define KPIs including guideline‑concordant utilization, payer approval rates, turnaround time, and cascade uptake.
• Cultivate KOL relationships with genetic counselors, geneticists, and hereditary cancer program leaders.

Benefits

• Employees regularly scheduled to work 20 or more hours per week are eligible for comprehensive benefits including: Medical, Dental, Vision, Life, STD/LTD, 401(k), Paid Time Off (PTO) or Flexible Time Off (FTO), Tuition Reimbursement and Employee Stock Purchase Plan.
• Employees regularly scheduled to work less than 20 hours, Casual, Intern, and Temporary employees are only eligible to participate in the 401(k) Plan.
• Employees who are regularly scheduled to work a 7 on/7 off schedule are eligible to receive all the foregoing benefits except PTO or FTO.

What This Job Offers

• Job Type: Full-time
• Career Level: Mid Level
• Number of Employees: 1-10 employees